Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0012 | 0.0286 | 0.0286 |
Echinococcus multilocularis | potassium:sodium hyperpolarization activated | 0.0008 | 0.008 | 0.008 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0079 | 0.3778 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0079 | 0.3778 | 0.3778 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0008 | 0.008 | 0.008 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0012 | 0.0286 | 0.0286 |
Echinococcus granulosus | multidrug and toxin extrusion protein 2 | 0.0079 | 0.3778 | 0.3778 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0043 | 0.1875 | 0.1875 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0043 | 0.1875 | 1 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0079 | 0.3778 | 1 |
Mycobacterium ulcerans | DNA-damage-inducible protein F DinF | 0.0007 | 0 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0012 | 0.0286 | 0.0286 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.004 | 0.1728 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0012 | 0.0286 | 0.0286 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0008 | 0.008 | 0.008 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0008 | 0.008 | 0.008 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0008 | 0.008 | 0.008 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0008 | 0.008 | 0.008 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0012 | 0.0286 | 0.1145 |
Echinococcus multilocularis | Multi antimicrobial extrusion protein MatE | 0.0072 | 0.3415 | 0.3415 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0046 | 0.2081 | 0.2081 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 1 | 1 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel | 0.0008 | 0.008 | 0.008 |
Echinococcus granulosus | potassium:sodium hyperpolarization activated | 0.0008 | 0.008 | 0.008 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0286 | 0.1145 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0012 | 0.0286 | 0.0286 |
Leishmania major | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0008 | 0.008 | 0.008 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel alpha 3 | 0.0008 | 0.008 | 0.008 |
Trypanosoma cruzi | membrane transporter protein, putative | 0.0079 | 0.3778 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel alpha 3 | 0.0008 | 0.008 | 0.008 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0008 | 0.008 | 0.0463 |
Trypanosoma brucei | MATE efflux family protein, putative | 0.0079 | 0.3778 | 1 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0008 | 0.008 | 0.008 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.158 | 0.8354 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0008 | 0.008 | 0.008 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0008 | 0.008 | 0.008 |
Treponema pallidum | hypothetical protein | 0.0007 | 0 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0043 | 0.1875 | 0.1875 |
Echinococcus multilocularis | geminin | 0.0197 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Echinococcus granulosus | voltage gated potassium channel | 0.0012 | 0.0286 | 0.0286 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0046 | 0.2081 | 0.2081 |
Giardia lamblia | Na+ driven multidrug efflux pump | 0.0007 | 0 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0008 | 0.008 | 0.0463 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0008 | 0.008 | 0.008 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0079 | 0.3778 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0008 | 0.008 | 0.008 |
Plasmodium falciparum | multidrug efflux pump, putative | 0.0007 | 0 | 0.5 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0079 | 0.3778 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 1 | 1 |
Giardia lamblia | Na+ driven multidrug efflux pump | 0.0007 | 0 | 0.5 |
Echinococcus multilocularis | multidrug and toxin extrusion protein 2 | 0.0079 | 0.3778 | 0.3778 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0008 | 0.008 | 0.008 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0043 | 0.1875 | 1 |
Giardia lamblia | Na+ driven multidrug efflux pump | 0.0007 | 0 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.004 | 0.1728 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 2.3 nM | Binding affinity towards Nociceptin/orphanin FQ (N/OFQ) receptor from recombinant HEK-293 cell membranes was determined using binding assay | ChEMBL. | 14980696 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.